Last Edition: September 24-25 2020,
Digitally Streamed from Lausanne


The Convergence in Oncology Summit is an international annual assembly of industry leaders, entrepreneurs, and investors active in the field of Oncology to debate and explore synergies that can accelerate the development of the most promising solutions in the field.

From diagnostics to therapeutics, rapid change in technology innovation modifies the landscape faster than any organizations can keep up with. Convergence of technologies from mature and emerging sectors are creating new opportunities that can significantly accelerate disruptive solutions that benefit patients globally.

The principal aim of this Summit is to promote development of new solutions through convergence and sharing of opportunities in the field of Oncology. The Summit is organized by professionals for professionals and we look forward to welcoming you digitally on our platform, for networking and sharing of knowledge among industry leaders, entrepreneurs, academics and investors.

Due to the current worldwide health situation, we will hold the meeting only digitally for the 2020 edition.

Session Highlights

This year’s Summit will focus on Prevention & Diagnostics, Therapy, and Digitization, with many opportunities to network and explore synergies.

The Summit is organized in several consecutive sessions led by a panel of industry leaders bringing their perspective to the topic, followed by several presentations by leading company CEOs covering innovative emerging and disrupting solutions relevant to the panel discussion.

Who should attend?

The annual event is attended by CEOs, entrepreneurs, investors, and thought leaders from both academia and industry to discuss and debate the key issues of global concern in Oncology.

Industry Leaders Entrepreneurs Investors
• Panel discussions • Company presentations • Investment outlook
Digitization    Prevention    Diagnostics    Therapeutics


Biopôle Lausanne is home of Life Sciences innovations in Switzerland. Biopôle hosts a vibrant community where industry and academia share a world-class combination of infrastructure, added value services, living space. Today, it houses more than 75 companies and clinical development teams, a startup incubator and 25 world-famous research groups. Biopôle SA is the owner of the site on which the Biopôle Lausanne life science campus is situated. Biopôle SA makes sure to insure the proper development of the site, to promote the site as a major place to be in the life sciences in Europe and to manage a lively community.

Salus Partners SA is a Swiss asset management firm based in Lausanne, Switzerland. The company has a special expertise in proven health technologies and seeks to generate exceptional returns while bringing good outcomes to society.




Journal, 22.04.2020
Journal, 18.03.2020
Journal, 18.03.2020
Journal, 18.03.2020
Journal, 18.03.2020
Journal, 18.03.2020
Journal, 18.03.2020

Contact us

Keep me posted

Subscribe our contact list to receive updates about the Convergence in Oncology Summit.